Mediphase Venture Partners logo

Mediphase Venture Partners

North America, Massachusetts, United States, Newton

Description

Mediphase Venture Partners is a Massachusetts-based venture capital firm focused on healthcare and life sciences companies.

Investor Profile

Mediphase Venture Partners has made 20 investments, with 0 in the past 12 months and 15% as lead.

Stage Focus

  • Series B (25%)
  • Series C (20%)
  • Series D (15%)
  • Series A (15%)
  • Series E (10%)
  • Series Unknown (10%)
  • Private Equity (5%)

Country Focus

  • United States (100%)

Industry Focus

  • Health Care
  • Biotechnology
  • Medical
  • Biopharma
  • Oncology
  • Pharmaceutical
  • Electronics
  • Mhealth
  • Software
  • Therapeutics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Mediphase Venture Partners frequently co-invest with?

OrbiMed
North America, New York, United States, New York
Co-Investments: 4
Seaflower Ventures
North America, Massachusetts, United States, Waltham
Co-Investments: 4
New Leaf Venture Partners
North America, New York, United States, New York
Co-Investments: 6
Sprout Group
North America, New York, United States, New York
Co-Investments: 5
5AM Ventures
North America, California, United States, Menlo Park
Co-Investments: 5
Skyline Ventures
North America, California, United States, Palo Alto
Co-Investments: 5
Intersouth Partners
North America, North Carolina, United States, Durham
Co-Investments: 4
Delphi Ventures
North America, California, United States, San Mateo
Co-Investments: 5
Lilly Ventures
North America, Indiana, United States, Indianapolis
Co-Investments: 3
Flagship Pioneering
North America, Massachusetts, United States, Cambridge
Co-Investments: 5

What are some of recent deals done by Mediphase Venture Partners?

Relypsa

Redwood City, California, United States

Relypsa is a biopharmaceutical company developing drugs for treating cardiovascular and renal diseases.

BiopharmaBiotechnologyHealth Care
Series CAug 14, 2012
Amount Raised: $80,000,000
Relypsa

Redwood City, California, United States

Relypsa is a biopharmaceutical company developing drugs for treating cardiovascular and renal diseases.

BiopharmaBiotechnologyHealth Care
Private EquityJul 1, 2012
Amount Raised: $62,400,000
Relypsa

Redwood City, California, United States

Relypsa is a biopharmaceutical company developing drugs for treating cardiovascular and renal diseases.

BiopharmaBiotechnologyHealth Care
Series BAug 8, 2011
Amount Raised: $70,129,747
Relypsa

Redwood City, California, United States

Relypsa is a biopharmaceutical company developing drugs for treating cardiovascular and renal diseases.

BiopharmaBiotechnologyHealth Care
Series BSep 13, 2010
Amount Raised: $70,000,000
Tetraphase Pharmaceuticals

Watertown, Massachusetts, United States

Tetraphase Pharmaceuticals is a company leveraging a dynamic drug engine targeted at several significant disease categories.

BiopharmaBiotechnologyHealth Care
Series CJun 1, 2010
Amount Raised: $45,000,000
ImpactRx

Mount Laurel, New Jersey, United States

ImpactRx operates as a promotion research organization for the pharmaceutical industry.

BiotechnologyHealth CarePharmaceuticalTherapeutics
Series EJan 11, 2010
Amount Raised: $1,200,000
Tetraphase Pharmaceuticals

Watertown, Massachusetts, United States

Tetraphase Pharmaceuticals is a company leveraging a dynamic drug engine targeted at several significant disease categories.

BiopharmaBiotechnologyHealth Care
Series BSep 22, 2009
Amount Raised: $25,000,000
Tetraphase Pharmaceuticals

Watertown, Massachusetts, United States

Tetraphase Pharmaceuticals is a company leveraging a dynamic drug engine targeted at several significant disease categories.

BiopharmaBiotechnologyHealth Care
Series AAug 7, 2008
Amount Raised: $15,000,000
Wellpartner

Portland, Oregon, United States

Wellpartner is a provider of pharmacy distribution solutions for health plans, Medicaid programs, and safety net organizations.

Health CareMedicalPharmaceutical
Series DAug 5, 2008
Amount Raised: $16,100,000
Concert Pharmaceuticals

Lexington, Massachusetts, United States

Concert Pharmaceuticals is a biotechnology company that uses deuterium chemistry to develop drug products that address patient needs.

BiotechnologyHealth CareMedicalPharmaceutical
Series CApr 30, 2008
Amount Raised: $37,000,000